Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Imposes Compulsory Recalls On Drug Companies (China)

This article was originally published in PharmAsia News

Executive Summary

Chinese drug makers and related companies will be responsible for recalling defective drugs from the market, Chinese authorities announced. The new rule also sets up a three-class system of recalls, to separate the intensity of the recalls and how quickly the drugs must be recalled, according to its level of danger. The companies, distributors and medical institutes also must notify the government of any reports they receive of adverse reactions to their products. The new plan gives the government authority to issue the recall itself and to punish a company that breaks the rule. (Click here for more ) "China Launches Nationwide System To Recall Harmful Drugs" China Post (12/13/07)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC065864

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel